Novo salvages happy ending for scrapped Parkinson’s cell therapy via deal with AI biotech

AI Summary

Novo has managed to salvage its Parkinson’s cell therapy after forming a deal with an AI biotech firm. This partnership is seen as a significant advance in the field of neural treatments, reflecting the increasing intersection of biotech and artificial intelligence.